caffeine has been researched along with suramin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Hicks, JL; Salter, MW | 1 |
| Begnini, J; Bellot, RG; De-La-Vega, DD; Frussa-Filho, R; Jimenez-Bernal, RE; Lopes, FP; Mello, CF; Schwartz, CC | 1 |
| O'Kane, EM; Stone, TW | 1 |
| Kato, M; Nakajima, Y; Sakuma, Y; Uchiyama, M | 1 |
| Bencini, C; Bruni, P; Formigli, L; Francini, F; Meacci, E; Nosi, D; Orlandini, SZ; Piperio, C; Quercioli, F; Tiribilli, B; Vassalli, M | 1 |
| Kiss, T; Molnár, G; Salánki, J | 1 |
| Bennett, MR; Lin, YQ | 1 |
| Hohenegger, M; Karel, A; Kassack, MU; Ullmann, H; Wolner, I | 1 |
| Groulx, N; Grygorczyk, R; Orlov, SN; Tatur, S | 1 |
| Bhat, MB; Carter, SM; Kanamarlapudi, V; Sigalas, C; Sitsapesan, R; Song, L; Stewart, R; Takeshima, H; Zaccai, NR | 1 |
16 other study(ies) available for caffeine and suramin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Calcium; Electrophysiology; Extracellular Space; Intracellular Membranes; Neuroglia; Neurons; Rats; Rats, Wistar; Spinal Cord; Suramin; Terpenes; Thapsigargin | 1994 |
Antinociceptive effect of purine nucleotides.
Topics: Analgesics; Animals; Caffeine; Male; Mice; Naloxone; Narcotic Antagonists; Nociceptors; Purine Nucleotides; Quinidine; Receptors, Purinergic P1; Receptors, Purinergic P2; Rosaniline Dyes; Suramin; Theophylline | 1996 |
Characterisation of ATP-induced facilitation of transmission in rat hippocampus.
Topics: Adenosine Deaminase; Adenosine Triphosphate; Animals; Caffeine; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Suramin; Synaptic Transmission; Theophylline | 2000 |
Purinergic regulation of intracellular Ca2+ concentration of rat pituitary folliculo-stellate cells in primary culture.
Topics: Adenosine Triphosphate; Animals; Caffeine; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cells, Cultured; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Estrenes; Inositol 1,4,5-Trisphosphate Receptors; Intracellular Fluid; Male; Membrane Proteins; Pituitary Gland, Anterior; Purinergic P2 Receptor Antagonists; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ryanodine; Suramin; Thapsigargin; Type C Phospholipases; Uridine Triphosphate | 2001 |
Sphingosine 1-phosphate induces Ca2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells.
Topics: Aniline Compounds; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cell Line; Cytoskeleton; Diglycerides; DNA-Binding Proteins; Extracellular Space; Fluorescent Dyes; I-kappa B Proteins; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Lysophospholipids; Mice; Microscopy, Confocal; Muscle Contraction; Muscle, Skeletal; NF-KappaB Inhibitor alpha; Potassium; Receptors, Lysophospholipid; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Sphingosine; Suramin; Xanthenes | 2002 |
Cadmium inhibits GABA-activated ion currents by increasing intracellular calcium level in snail neurons.
Topics: Animals; Cadmium; Caffeine; Calcium; Calcium Signaling; Central Nervous System Stimulants; Chloride Channels; GABA Antagonists; gamma-Aminobutyric Acid; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Ion Channels; Lymnaea; Microinjections; Neurons; Pertussis Toxin; Signal Transduction; Suramin | 2004 |
Varicosity-Schwann cell interactions mediated by ATP in the mouse vas deferens.
Topics: Adenosine Triphosphate; Adrenergic Fibers; Aniline Compounds; Animals; Caffeine; Calcium; Cell Count; Drug Interactions; Electric Stimulation; Estrenes; Evoked Potentials; Fluorescent Dyes; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Organic Chemicals; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Pyrrolidinones; Quinazolines; S100 Proteins; Schwann Cells; Suramin; Time Factors; Triazoles; Uridine Triphosphate; Vas Deferens; Xanthenes | 2005 |
Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676.
Topics: Adenylyl Imidodiphosphate; Allosteric Regulation; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Calmodulin; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Inhibitory Concentration 50; Ion Channel Gating; Kinetics; Muscle, Skeletal; Myocardium; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Suramin | 2005 |
Ca2+-dependent ATP release from A549 cells involves synergistic autocrine stimulation by coreleased uridine nucleotides.
Topics: Adenosine Triphosphate; Apyrase; Autocrine Communication; Caffeine; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Cell Line, Tumor; Endoplasmic Reticulum; Enzyme Inhibitors; Epithelial Cells; Humans; Hydrolysis; Hypotonic Solutions; Inositol 1,4,5-Trisphosphate Receptors; Lung Neoplasms; Osmotic Pressure; Paracrine Communication; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Suramin; Thapsigargin; Time Factors; Uracil Nucleotides | 2007 |
Single-channel characterization of the rabbit recombinant RyR2 reveals a novel inactivation property of physiological concentrations of ATP.
Topics: Adenosine Triphosphate; Animals; Caffeine; Calcium; Calcium Channel Blockers; Cell Line; DNA, Complementary; Humans; Ion Channel Gating; Ligands; Rabbits; Recombinant Proteins; Ryanodine Receptor Calcium Release Channel; Suramin | 2008 |